Back to BRANDES INVESTMENT PARTNERS, LP BRANDES INVESTMENT PARTNERS, LP

TAKTAK
29 quarters

Position history for BRANDES INVESTMENT PARTNERS, LPBRANDES INVESTMENT PARTNERS, LP's holdings in TAKEDA PHARMACEUTICAL CO LTD

BRANDES INVESTMENT PARTNERS, LP holds 4.4M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $82.1M as of 2026-Q1. The position was increased (+14.1% shares). TAK represents 0.6% of BRANDES INVESTMENT PARTNERS, LP's portfolio.

Current Value

$82.1M

Current Shares

4.4M

Total Value Change

+$52M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
4.4M
+14.1%
$82.1M0.6%$18.08
48
2025-Q4
Decreased
3.9M
-1.3%
$60.5M0.5%$15.63
0
2025-Q3
Increased
3.9M
+5.9%
$57.6M0.5%$14.62
37
2025-Q2
Increased
3.7M
+5.9%
$57.4M0.5%$15.10
44
2025-Q1
Increased
3.5M
+15.3%
$52.1M0.5%$14.71
47
2024-Q4
Decreased
3M
-5.9%
$40.2M0.4%$12.87
0
2024-Q3
Increased
3.2M
+22.6%
$46M0.5%$13.89
50
2024-Q2
Decreased
2.6M
-9.2%
$34M0.4%$12.36
0
2024-Q1
Increased
2.9M
+9.5%
$40.3M0.5%$13.27
45
2023-Q4
Increased
2.7M
+47.1%
$37.8M0.6%$13.36
56
2023-Q3
Increased
1.8M
+2.1%
$27.9M0.5%$14.48
41
2023-Q2
Decreased
1.8M
-2.9%
$27.7M0.6%$14.70
0
2023-Q1
Increased
1.8M
+1435.2%
$30M0.6%$15.31
65
2022-Q4
Decreased
118,420
-93.7%
$1.8M0.1%$14.60
0
2022-Q3
Decreased
1.9M
-7.5%
$24.3M0.6%$12.14
0
2022-Q2
Decreased
2M
-4.1%
$28.4M0.7%$12.97
0
2022-Q1
Increased
2.1M
+20.6%
$30.2M0.6%$13.51
48
2021-Q4
Decreased
1.7M
-13.2%
$23.9M0.5%$12.71
0
2021-Q3
Decreased
2M
-3.2%
$33M0.7%$15.27
0
2021-Q2
Increased
2.1M
+18.3%
$35M0.8%$15.76
48
2021-Q1
Increased
1.8M
+5.9%
$32.3M0.8%$17.18
43
2020-Q4
Increased
1.7M
+14.3%
$30.2M0.8%$17.02
46
2020-Q3
Decreased
1.5M
-12.9%
$26M0.9%$16.98
0
2020-Q2
Decreased
1.7M
-7.1%
$30M0.9%$16.95
0
2020-Q1
Increased
1.8M
+5.0%
$27.3M1.0%$14.63
43
2019-Q4
Decreased
1.7M
-7.0%
$33.8M0.8%$18.41
0
2019-Q3
Increased
1.8M
+37.2%
$31.7M0.8%$16.23
53
2019-Q2
Decreased
1.3M
-9.1%
$23.8M0.5%$16.57
0
2019-Q1
New
1.5M
-
$30.1M0.7%$19.07
56

Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used